Cross‐resistance, fitness costs, and biochemical mechanism of laboratory‐selected resistance to tenvermectin A in Plutella xylostella

Abstract

BACKGROUND Tenvermectin A is a new avermectin derivative that has good insecticidal and acaricidal effects. In order to study the resistance of Plutella xylostella to tenvermectin A, a sensitive strain (SS) and a laboratory‐selected tenvermectin A‐resistant strain (RS, 33.57‐fold) were used to evaluate cross‐resistance and fitness costs as well as to determine the resistance mechanism. RESULTS There was no cross‐resistance with common pesticides except for moderate cross‐resistance with cypermethrin (resistance ratio = 10.26‐fold) observed in RS. The activities of metabolic enzymes were measured, and the results showed that mixed function oxidase (MFO) and carboxylate esterase (CarE) in RS increased significantly by 2.92‐ and 2.86‐fold, respectively, compared with SS. In addition, there was no obvious difference in glutathione‐S‐transferase (GST), which indicated that enhanced MFO and CarE activities may be the main mechanisms of detoxification. In the four typical resistance‐related genes, expression of GluCl (4.86‐fold), ABCC2 (3.85‐fold), and CYP6 (2.94‐fold) in RS were significantly promoted, but expression of GST was not. The clone and sequence of the PxGluClα subunit displayed six mutations that could lead to changes in the amino acid residues. CONCLUSION High suitability related to tenvermectin A resistance was observed in RS, and it was found that the developmental stages of RS were significantly shortened and the survival rate of females was reduced. In addition, the mechanism of resistance to tenvermectin A may be regulated by the glutamate‐gated chloride channel, ATP‐binding cassette transporter, and MFO. In general, the study of resistance and biochemical mechanisms can provide beneficial and rational information for the management of resistance in P. xylostella. © 2021 Society of Chemical Industry

CRISPR/Cas9-Mediated Knockout of the PxJHBP Gene Resulted in Increased Susceptibility to Bt Cry1Ac Protoxin and Reduced Lifespan and Spawning Rates in Plutella xylostella

“…Plutella xylostella , a devastating pest of cruciferous vegetables, holds the distinction of being the first insect to develop resistance to Bacillus thuringiensis (Bt) in the field . Its resistance to multiple insecticides has escalated control costs to an estimated $4–$5 billion annually . To combat this evolving resistance, researchers are turning to Bt crops as a potential solution. , One promising approach is the pyramid control strategy, which combines transgenic and RNAi technologies to target key insect hormones, such as JH and 20-hydroxyecdysone (20E), as demonstrated in the successful control of Helicoverpa armigera .…”

CYP6CX2 and CYP6CX3 mediate thiamethoxam resistance in field whitefly, Bemisia tabaci (Hemiptera:Aleyrodidae)

“…Insecticide resistance is an on-going threat to agriculture, the environment, and human health worldwide. Although addressing the issue of insecticide resistance often faces with challenges because of the ever-increasing evolution of resistance cases, elucidating the mechanism conferring such resistance is therefore of particular importance to sustainable pest management (Douglas 2018, Gould et al 2018, Zhu et al 2021). Of the cases reported, the resistance to neonicotinoids, the world's most heavily used insecticides, has emerged in various insect pests around the world (Bass et al 2015, Casida 2018).…”

Acyltransferase Domain Swapping for the Production of Tenvermectin B Metabolites in Genetically Engineered Strain Streptomyces avermitilis HU02

“…TVMs A and B showed enhanced insecticidal activity against Tetranychus cinnabarinus, Bursaphelenchus xylophilus, Caenorhabditis elegans, and Mythimna separata. Additionally, they have no cross-resistance to chlorantraniliprole, spinosad, and avermectin . Therefore, TVMs A and B are considered to be the potential candidates for the development of a new generation of agricultural and veterinary drugs.…”

“…Additionally, they have no cross-resistance to chlorantraniliprole, spinosad, and avermectin. 15 Therefore, TVMs A and B are considered to be the potential candidates for the development of a new generation of agricultural and veterinary drugs. In particular, TVM-B is being developed as a new insecticide.…”